Skip to main content

CORRECTION article

Front. Cell Dev. Biol., 28 January 2021
Sec. Membrane Traffic and Organelle Dynamics
Volume 9 - 2021 | https://doi.org/10.3389/fcell.2021.631655
This article is part of the Research Topic Peroxisome Biology: Breakthroughs, Challenges and Future Directions View all 24 articles

Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor

This article is a correction to:

  1. Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor

    1. Read original article
\nRinse W. Barendsen,Rinse W. Barendsen1,2Inge M. E. DijkstraInge M. E. Dijkstra1Wouter F. VisserWouter F. Visser3Mariëlle AldersMariëlle Alders4Jet BliekJet Bliek4Anita BoelenAnita Boelen5Marelle J. BouvaMarelle J. Bouva6Saskia N. van der CrabbenSaskia N. van der Crabben4Ellen ElsinghorstEllen Elsinghorst7Ankie G. M. van GorpAnkie G. M. van Gorp7Annemieke C. Heijboer,Annemieke C. Heijboer5,8Mandy JansenMandy Jansen9Yorrick R. J. JaspersYorrick R. J. Jaspers1Henk van LentheHenk van Lenthe1Ingrid Metgod,Ingrid Metgod5,8Christiaan F. MooijChristiaan F. Mooij10Elise H. C. van der SluijsElise H. C. van der Sluijs1A. S. Paul van TrotsenburgA. S. Paul van Trotsenburg10Rendelien K. Verschoof-PuiteRendelien K. Verschoof-Puite9Frdric M. VazFrédéric M. Vaz1Hans R. WaterhamHans R. Waterham1Frits A. WijburgFrits A. Wijburg2Marc EngelenMarc Engelen11Eugnie DekkersEugènie Dekkers7Stephan Kemp, Stephan Kemp1,11*
  • 1Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam UMC, Amsterdam Gastroenterology and Metabolism, University of Amsterdam, Amsterdam, Netherlands
  • 2Pediatric Metabolic Diseases, Amsterdam UMC, Emma Children's Hospital, University of Amsterdam, Amsterdam, Netherlands
  • 3Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands
  • 4Department of Clinical Genetics, Amsterdam UMC, Amsterdam Reproduction & Development, University of Amsterdam, Amsterdam, Netherlands
  • 5Department of Clinical Chemistry, Neonatal Screening Laboratory, Endocrine Laboratory, Amsterdam UMC, Amsterdam Gastroenterology and Metabolism, University of Amsterdam, Amsterdam, Netherlands
  • 6Reference Laboratory for Neonatal Screening, Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands
  • 7Centre for Population Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands
  • 8Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC, Amsterdam Gastroenterology and Metabolism, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
  • 9Department for Vaccine Supply and Prevention Programmes, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands
  • 10Department of Pediatric Endocrinology, Amsterdam UMC, Emma Children's Hospital, University of Amsterdam, Amsterdam, Netherlands
  • 11Department of Pediatric Neurology, Amsterdam UMC, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands

A Corrigendum on
Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor

by Barendsen, R. W., Dijkstra, I. M. E., Visser, W. F., Alders, M., Bliek, J., Boelen, A., et al. (2020). Front. Cell Dev. Biol. 8:499. doi: 10.3389/fcell.2020.00499

In the original article, there was a mistake in the legend for Figure 6 as published. Three numbers were not in superscript which changed concentrations and there was an error in dosage. The correct legend appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Figure 6 | Our patient- and parent-friendly, multidisciplinary, centralized follow-up protocol. 1All follow-up appointments will be scheduled on the same day (Wednesday); 2Before 10:00 AM; 315 μg/kg/dose, max. 125 μg/dose; 410 μg/dL = 276 nmol/L, 18 μg/dL = 497 nmol/L; 510 mg/m2/day in three equal doses (3 times per day 33.3% of the total daily dose); when older than 6 months: 50% early in the morning, and 25% early in the afternoon and evening. Adrenal surveillance protocol adapted and modified from Regelmann et al. (2018). Abbreviations: ACTH, adrenocorticotropic hormone; K, potassium; Na, sodium; PRA, plasma renin activity; Q&A, questions & answers.

References

Regelmann, M. O., Kamboj, M. K., Miller, B. S., Nakamoto, J. M., Sarafoglou, K., Shah, S., et al. (2018). Adrenoleukodystrophy: guidance for adrenal surveillance in males identified by newborn screen. J. Clin. Endocrinol. Metab. 103, 4324–4331. doi: 10.1210/jc.2018-00920

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: adrenoleukodystrophy, peroxisomes, newborn screening, neonatal, gender, heel prick, dried bloodspots, X chromosome

Citation: Barendsen RW, Dijkstra IME, Visser WF, Alders M, Bliek J, Boelen A, Bouva MJ, van der Crabben SN, Elsinghorst E, van Gorp AGM, Heijboer AC, Jansen M, Jaspers YRJ, van Lenthe H, Metgod I, Mooij CF, van der Sluijs EHC, van Trotsenburg ASP, Verschoof-Puite RK, Vaz FM, Waterham HR, Wijburg FA, Engelen M, Dekkers E and Kemp S (2021) Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor. Front. Cell Dev. Biol. 9:631655. doi: 10.3389/fcell.2021.631655

Received: 20 November 2020; Accepted: 11 January 2021;
Published: 28 January 2021.

Edited and reviewed by: Maya Schuldiner, Weizmann Institute of Science, Israel

Copyright © 2021 Barendsen, Dijkstra, Visser, Alders, Bliek, Boelen, Bouva, van der Crabben, Elsinghorst, van Gorp, Heijboer, Jansen, Jaspers, van Lenthe, Metgod, Mooij, van der Sluijs, van Trotsenburg, Verschoof-Puite, Vaz, Waterham, Wijburg, Engelen, Dekkers and Kemp. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Stephan Kemp, cy5rZW1wJiN4MDAwNDA7YW1zdGVyZGFtdW1jLm5s

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.